Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Buhai Wang"'
Autor:
Yichun Zeng, Liying Zhang, Yichen Liang, Xian Zhang, Lei Li, Maoqi Wang, Jingliang Guo, Qiuxian Li, Jin Cao, Juan J. Gu, Buhai Wang
Publikováno v:
Cancer Medicine, Vol 12, Iss 13, Pp 13928-13941 (2023)
Abstract Background Currently, immune checkpoint blockers (ICB) and radiotherapy (RT) combination therapy is broadly applied in non‐small cell lung cancer (NSCLC) patients. However, meta‐analysis about safety and efficacy of RT + ICB versus ICB h
Externí odkaz:
https://doaj.org/article/302bb34d569445298a091f62ee3d33bd
Autor:
Pengwei Yan, Haitao Yin, Wenjie Guo, Xiangdong Sun, Feng Li, Shengfu Huang, Xiuhua Bian, Feijiang Wang, Fuzheng Zhang, Buhai Wang, Hongping Zhou, Chong Zhou, Li Yin, Xuesong Jiang, Ning Jiang, Jianfeng Wu, Juying Liu, Dan Song, Xia He
Publikováno v:
Cancer Medicine, Vol 9, Iss 17, Pp 6166-6172 (2020)
Abstract Background This study aimed to compare the efficacy and toxicity of raltitrexed (Saiweijian®) plus cisplatin (SP regimen) and 5‐fluorouracil plus cisplatin (FP regimen) as concurrent chemoradiotherapy (CCRT) in patients with locally advan
Externí odkaz:
https://doaj.org/article/8ecf8ec8f0a84584ab3922123a5883a5
Autor:
Haitao Yin, Xia He, Wen-Jie Guo, Buhai Wang, Hongping Zhou, Dan Song, Fuzheng Zhang, Chong Zhou, Ning Jiang, Pengwei Yan, Xuesong Jiang, Feijiang Wang, Shengfu Huang, Xiuhua Bian, Xiangdong Sun, Juying Liu, Li Yin, Jianfeng Wu, Feng Li
Publikováno v:
Cancer Medicine, Vol 9, Iss 17, Pp 6166-6172 (2020)
Cancer Medicine
Cancer Medicine
Background This study aimed to compare the efficacy and toxicity of raltitrexed (Saiweijian®) plus cisplatin (SP regimen) and 5‐fluorouracil plus cisplatin (FP regimen) as concurrent chemoradiotherapy (CCRT) in patients with locally advanced nasop